b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">30662865</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>22</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Print">2229-5151</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>8</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <MedlineDate>2018 Oct-Dec</MedlineDate>\n                    </PubDate>\n                </JournalIssue>\n                <Title>International journal of critical illness and injury science</Title>\n                <ISOAbbreviation>Int J Crit Illn Inj Sci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Assessment of acute kidney injury in neurologically and traumatically injured intensive care patients receiving large vancomycin doses.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>194-200</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.4103/IJCIIS.IJCIIS_39_18</ELocationID>\n            <Abstract>\n                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Previous reports note that in a mixed patient population, vancomycin doses &gt;4 g/day are associated with increased rates of acute kidney injury (AKI).</AbstractText>\n                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">The objective of the study is to determine if vancomycin regimens &gt;4 g/day are associated with a higher incidence of AKI in neurocritical care unit (NCCU) and trauma/burn Intensive Care Unit (TBICU) patients.</AbstractText>\n                <AbstractText Label="Materials and Methods" NlmCategory="UNASSIGNED">This single-centered, retrospective study enrolled adult patients initiated on vancomycin in the NCCU and TBICU at an academic medical center during 2016. Based on maximum steady-state dose exposure, patients were separated into two groups: \xe2\x89\xa44 g/day and &gt;4 g/day. The primary outcome of incidence of AKI was defined by the AKI Network criteria.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 284 patients were screened for eligibility; 165 patients met inclusion criteria, 98 patients received \xe2\x89\xa44 g/day and 67 patients received &gt;4 g/day. The &gt;4 g/day group had a lower mean age (32.6\xc2\xb111.1 vs. 47.8\xc2\xb116.2, <i>P</i> &lt; 0.001), included more male patients (81% vs. 60%, <i>P</i> = 0.008), were more often treated for a central nervous system infection (31% vs. 11%, <i>P</i> = 0.001), had, on average, more concomitant use of nephrotoxic drugs (2.2\xc2\xb11.2 vs. 1.8\xc2\xb10.9, <i>P</i> = 0.02) and had a higher exposure to contrast (94% vs. 79%, <i>P</i> &lt; 0.001). The primary outcome of AKI occurred in 14 patients receiving \xe2\x89\xa44 g/day and five patients receiving &gt;4 g/day which was not statistically significant (14% vs. 7%, <i>P</i> = 0.22).</AbstractText>\n                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Our results indicate that administering &gt;4 g/day of vancomycin to achieve therapeutic vancomycin troughs does not appear to lead to an increased incidence of AKI in a mixed NCCU and TBICU population.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>May</LastName>\n                    <ForeName>Casey C</ForeName>\n                    <Initials>CC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Erwin</LastName>\n                    <ForeName>Beth L</ForeName>\n                    <Initials>BL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Childress</LastName>\n                    <ForeName>Margaret</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cortopassi</LastName>\n                    <ForeName>Josh</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Curtis</LastName>\n                    <ForeName>Garrett</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kilpatrick</LastName>\n                    <ForeName>Tyson</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Taylor</LastName>\n                    <ForeName>Jennifer</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Vance</LastName>\n                    <ForeName>Bonnie</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wylie</LastName>\n                    <ForeName>Doug</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pharmacy, University of Alabama at Birmingham Medical Center, Birmingham, AL, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>India</Country>\n            <MedlineTA>Int J Crit Illn Inj Sci</MedlineTA>\n            <NlmUniqueID>101571136</NlmUniqueID>\n            <ISSNLinking>2229-5151</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Neurology</Keyword>\n            <Keyword MajorTopicYN="N">pharmacodynamics</Keyword>\n            <Keyword MajorTopicYN="N">pharmacokinetics</Keyword>\n            <Keyword MajorTopicYN="N">trauma</Keyword>\n            <Keyword MajorTopicYN="N">vancomycin</Keyword>\n        </KeywordList>\n        <CoiStatement>There are no conflicts of interest.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30662865</ArticleId>\n            <ArticleId IdType="doi">10.4103/IJCIIS.IJCIIS_39_18</ArticleId>\n            <ArticleId IdType="pii">IJCIIS-8-194</ArticleId>\n            <ArticleId IdType="pmc">PMC6311967</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2000 May;44(5):1356-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10770777</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Infect Dis. 2004 Nov 1;39(9):1267-84</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15494903</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nephrol Dial Transplant. 2005 Apr;20(4):747-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15701668</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2006 Jun 8;354(23):2473-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16760447</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br J Clin Pharmacol. 2007 May;63(5):583-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17166188</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Care. 2007;11(2):R31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17331245</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18227177</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Infect Dis. 2009 Aug 1;49(3):325-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19569969</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Trauma. 2009 Oct;67(4):802-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19820588</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Pharmacokinet. 2010;49(1):1-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20000886</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anesth Analg. 2010 Dec;111(6):1505-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21048095</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Infect Dis. 2011 Feb 1;52(3):e18-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21208910</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Care. 2011;15(1):R49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21291554</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2011 Jul;55(7):3278-83</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21576448</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Nephrol. 2011 Jul 19;7(9):539-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21769107</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Antimicrob Agents Chemother. 2011 Dec;55(12):5475-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21947388</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Antimicrob Agents. 2012 May;39(5):420-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22386742</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurosurg. 2013 Feb;118(2):297-301</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23121433</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurocrit Care. 2013 Oct;19(2):210-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23907742</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Pharm Ther. 2013 Dec;38(6):462-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23924288</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rev Bras Ter Intensiva. 2014 Jan-Mar;26(1):13-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24770684</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Care. 2014 Dec 05;18(6):654</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25475123</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ther Drug Monit. 2015 Oct;37(5):609-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25627406</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurocrit Care. 2015 Dec;23(3):374-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25761425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurocrit Care. 2016 Oct;25(2):250-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26942732</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ther Drug Monit. 2016 Dec;38(6):706-710</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27681114</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Trauma Acute Care Surg. 2017 Apr;82(4):665-671</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28129261</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Infect Dis. 2017 Feb 14;:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28203777</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Med Toxicol Adverse Drug Exp. 1988 Sep-Oct;3(5):376-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3057327</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 1978 Oct 26;299(17):915-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">692596</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'